|Articles|June 1, 2003

June 2003 - Special Issue
Volume 9
Issue 1 SP

Hospital Cost Drivers: An Evaluation of 1998-2001 State-Level Data

Author(s)Joel W. Hay, PhD

Download PDF: Hospital Cost Drivers: An Evaluation of 1998-2001 State-Level Data

Articles in this issue

about 23 years ago

Article

New Evidence to Explain Rising Healthcare Costs

about 23 years ago

Article

Understanding the Underlying Drivers of Inpatient Cost Growth: A Literature Review

about 23 years ago

Article

Drivers of Expenditure Growth in Outpatient Care Services

about 23 years ago

Article

Drivers of Healthcare Expenditures Associated With Physician Services

about 23 years ago

Article

Exploring the Relationship Between Inpatient Hospital Costs and Quality of Care

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

ByAayush Sisodia, MSHI, BDS

Published: August 6th 2026 | Updated: August 31st 2026

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Hospital Cost Drivers: An Evaluation of 1998-2001 State-Level Data

Articles in this issue

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Trending on AJMC

FDA Approves Moderna’s mRNA Flu Vaccine After Phase 3 Success

Avoiding TNF Cycling: When to Switch Drug Classes in Rheumatoid Arthritis

Predicting GLP-1 Discontinuation From Pharmacy Claims

Patients With MASLD Had More Than 2 Times Higher Odds of Eosinophilic Esophagitis Across Age Groups

Full Data Published Showing 87% CR at 3 Years for Epcoritamab Plus BR in First-Line FL

A Look at PBM Reform and Transparency: Payer, Provider and Patient Impact

Hospital Cost Drivers: An Evaluation of 1998-2001 State-Level Data

Articles in this issue

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Trending on AJMC

FDA Approves Moderna’s mRNA Flu Vaccine After Phase 3 Success

Avoiding TNF Cycling: When to Switch Drug Classes in Rheumatoid Arthritis

Predicting GLP-1 Discontinuation From Pharmacy Claims

Patients With MASLD Had More Than 2 Times Higher Odds of Eosinophilic Esophagitis Across Age Groups

Full Data Published Showing 87% CR at 3 Years for Epcoritamab Plus BR in First-Line FL